The EORTC 22861 study rand omized patients with anal cancer to radiation therapy alone versus radiation therapy with concurrent 5-fluorouracil and mitomycin-C. What benefit(s) were seen with the addition of chemotherapy?
The EORTC 22861 study rand omized patients with anal cancer to radiation therapy alone versus radiation therapy with concurrent 5-fluorouracil and mitomycin-C. What benefit(s) were seen with the addition of chemotherapy?